AVGO is bullish on its 1D technical outlook (RSI = 64.250, MACD = 3.500, ADX = 29.483) as last week it crossed and close over its 1W MA50 and on the current 1W candle it is about to close over the 0.618 Fibonacci retracement level as well. This is similar to the November-December 2022 fractal that followed after the last major market bottom. Both sequences bottomed on the same 1W RSI level (34.80), so the structures share more similarities than differences. Since the 3 year pattern is a Channel Up, the stock is now on the new bullish wave aiming for the next HH. The 2022 rebound reached the 1.618 Fib extension before consolidating for weeks, so our long term target is the current 1.618 Fib (TP = $350.00).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
Telegram: t.me/investingscope
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Telegram: t.me/investingscope
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.